重大资产重组预案公布 向日葵“一字”涨停

Group 1 - The company, Sunflower, has announced a non-public issuance plan to acquire 100% equity of Xipu Materials and 40% equity of Beid Pharmaceutical, which is expected to constitute a major asset restructuring for the listed company [2] - Prior to this transaction, the company's main business focused on the pharmaceutical sector, including the research, manufacturing, and sales of anti-infection, cardiovascular, and digestive system drugs [2] - Xipu Materials specializes in the research, manufacturing, and sales of high-end semiconductor materials, with products used in critical processes of semiconductor manufacturing [2] Group 2 - The acquisition is expected to enhance the asset quality of the listed company and promote its long-term development [2] - Post-transaction, the company will enter the high-end semiconductor materials sector, creating a second growth curve and accelerating its transformation towards new productive forces [2] - This move aims to add new profit growth points for the company [2]